Table of Content


Introduction
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Overview
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Therapeutics Development
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Therapeutics Assessment
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Companies Involved in Therapeutics Development
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Drug Profiles
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Dormant Products
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Discontinued Products
Tyrosine Protein Kise JAK1 (Janus Kise 1 or JAK1 or EC 2.7.10.2) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Top 10 Indications, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021


List of Tables


Number of Products under Development by Stage of Development, 2021
Number of Products under Development by Therapy Areas, 2021
Number of Products under Development by Indications, 2021
Number of Products under Development by Indications, 2021 (Contd..1)
Number of Products under Development by Indications, 2021 (Contd..2)
Number of Products under Development by Indications, 2021 (Contd..3)
Number of Products under Development by Indications, 2021 (Contd..4)
Number of Products under Development by Indications, 2021 (Contd..5)
Number of Products under Development by Companies, 2021
Number of Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021
Products under Development by Companies, 2021 (Contd..1)
Products under Development by Companies, 2021 (Contd..2)
Products under Development by Companies, 2021 (Contd..3)
Products under Development by Companies, 2021 (Contd..4)
Products under Development by Companies, 2021 (Contd..5)
Products under Development by Companies, 2021 (Contd..6)
Products under Development by Companies, 2021 (Contd..7)
Products under Development by Companies, 2021 (Contd..8)
Products under Development by Companies, 2021 (Contd..9)
Products under Development by Companies, 2021 (Contd..10)
Products under Development by Companies, 2021 (Contd..11)
Products under Development by Companies, 2021 (Contd..12)
Products under Development by Companies, 2021 (Contd..13)
Products under Development by Companies, 2021 (Contd..14)
Products under Development by Companies, 2021 (Contd..15)
Number of Products under Investigation by Universities/Institutes, 2021
Products under Investigation by Universities/Institutes, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Pipeline by AbbVie Inc, 2021
Pipeline by Aclaris Therapeutics Inc, 2021
Pipeline by Alexion Pharmaceuticals Inc, 2021
Pipeline by Ashvattha Therapeutics LLC, 2021
Pipeline by Astellas Pharma Inc, 2021
Pipeline by AstraZeneca Plc, 2021
Pipeline by Bristol-Myers Squibb Co, 2021
Pipeline by Celon Pharma SA, 2021
Pipeline by Concert Pharmaceuticals Inc, 2021
Pipeline by Dizal (Jiangsu) Pharmaceutical Co Ltd, 2021
Pipeline by Eli Lilly and Co, 2021
Pipeline by Galapagos NV, 2021
Pipeline by GlaxoSmithKline Plc, 2021
Pipeline by Han Wha Pharma Co Ltd, 2021
Pipeline by Hangzhou East China Pharmaceutical Group Co Ltd, 2021
Pipeline by HK inno.N Corp, 2021
Pipeline by Impetis Biosciences Ltd, 2021
Pipeline by Incyte Corp, 2021
Pipeline by Japan Tobacco Inc, 2021
Pipeline by Jiangsu Carephar Pharmaceutical Co Ltd, 2021
Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021
Pipeline by Jiangsu Simcere Pharmaceutical Co Ltd, 2021
Pipeline by Merck & Co Inc, 2021
Pipeline by Nippon Shinyaku Co Ltd, 2021
Pipeline by Novartis AG, 2021
Pipeline by Pfizer Inc, 2021
Pipeline by Sareum Holdings Plc, 2021
Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd, 2021
Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021
Pipeline by Sierra Oncology Inc, 2021
Pipeline by Theravance Biopharma Inc, 2021
Pipeline by TLL Pharmaceutical LLC, 2021
Pipeline by Wuxi Fuxin Pharmaceutical Research and Development Co Ltd, 2021
Dormant Products, 2021
Dormant Products, 2021 (Contd..1)
Dormant Products, 2021 (Contd..2)
Dormant Products, 2021 (Contd..3)
Discontinued Products, 2021
Discontinued Products, 2021 (Contd..1)